Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR
Advertisement

Paradigm Biopharmaceuticals (PAR) Similar Shares

Compare
40 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Paradigm Biopharmaceuticals
AU$0.34
$145.70M
41.67%
1 Buy
0 Hold
0 Sell
Moderate Buy
Imugene
AU$0.30
$104.06M
-78.48%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alterity Therapeutics
AU$0.01
AU$97.88M
0.00%
Pharmaust Limited
AU$0.11
€61.49M
-3.38
-45.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Recce Pharmaceuticals Ltd.
AU$0.41
AU$125.79M
-4.83
-13.00%
Arovella Therapeutics Limited
AU$0.09
AU$106.68M
-13.09
-55.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:PAR
Paradigm Biopharmaceuticals
0.34
0.11
47.83%
AU:IMU
Imugene
0.30
-1.09
-78.48%
AU:ATH
Alterity Therapeutics
0.01
0.00
0.00%
AU:NUZ
Pharmaust Limited
0.11
-0.08
-40.54%
AU:RCE
Recce Pharmaceuticals Ltd.
0.44
-0.04
-8.33%
AU:ALA
Arovella Therapeutics Limited
0.09
-0.10
-52.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis